Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Cheng

Showing results (671-680 of 768) with videos related to

Pageof 77
Sort By:
Blood Cancer Journal|March 30, 2022
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implicationYu-Jia Huo, Peng-Peng Xu, Di Fu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 4, 2023
CTLA-4 blockade induces tumor pyroptosis via CD8<sup>+</sup> T cells in head and neck squamous cell carcinomaShuo Wang, Zhi-Zhong Wu, Su-Wen Zhu, et al.
BMC Immunology|January 12, 2012
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejectionChung-Her Jenh, Mary Ann Cox, Long Cui, et al.
Surgery Today|July 11, 2025
A graft-to-recipient weight ratio of less than 0.7% under portal venous hemodynamics monitoring is a risk factor for early graft loss after living donor liver transplantationNiang-Cheng Lin, Cheng-Yen Chen, Hao-Jan Lei, et al.
Frontiers in Oncology|October 24, 2022
Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphomaMeng-Ke Liu, Li-Li Cheng, Hong-Mei Yi, et al.
Advanced Healthcare Materials|December 8, 2022
Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer ImmunotherapyShu-Cheng Wan, Meng-Jie Ye, Qi-Chao Yang, et al.
The American Journal of Medicine|May 26, 2012
Awareness of kidney disease and relationship to end-stage renal disease and mortalityAdam Whaley-Connell, Michael G Shlipak, Lesley A Inker, et al.
Blood|May 21, 2026
N6-methyladenosine reader IGF2BP2 in T-cell lymphomaSong Hu, Yao Qin, Hong-Mei Yi, et al.
Pediatric Transplantation|January 17, 2022
Safety and long-term outcomes of early liver transplantation for pediatric methylmalonic acidemia patientsNiang-Cheng Lin, Hsin-Lin Tsai, Cheng-Yen Chen, et al.
Signal Transduction and Targeted Therapy|January 19, 2025
Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphomaZhong Zheng, Jian-Biao Wang, Rui Sun, et al.
Pageof 77

Showing results (671-680 of 768) with videos related to

Sort By:
Pageof 77
Blood Cancer Journal|March 30, 2022
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implicationYu-Jia Huo, Peng-Peng Xu, Di Fu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 4, 2023
CTLA-4 blockade induces tumor pyroptosis via CD8<sup>+</sup> T cells in head and neck squamous cell carcinomaShuo Wang, Zhi-Zhong Wu, Su-Wen Zhu, et al.
BMC Immunology|January 12, 2012
A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejectionChung-Her Jenh, Mary Ann Cox, Long Cui, et al.
Surgery Today|July 11, 2025
A graft-to-recipient weight ratio of less than 0.7% under portal venous hemodynamics monitoring is a risk factor for early graft loss after living donor liver transplantationNiang-Cheng Lin, Cheng-Yen Chen, Hao-Jan Lei, et al.
Frontiers in Oncology|October 24, 2022
Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC/BCL2 double expressor lymphomaMeng-Ke Liu, Li-Li Cheng, Hong-Mei Yi, et al.
Advanced Healthcare Materials|December 8, 2022
Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer ImmunotherapyShu-Cheng Wan, Meng-Jie Ye, Qi-Chao Yang, et al.
The American Journal of Medicine|May 26, 2012
Awareness of kidney disease and relationship to end-stage renal disease and mortalityAdam Whaley-Connell, Michael G Shlipak, Lesley A Inker, et al.
Blood|May 21, 2026
N6-methyladenosine reader IGF2BP2 in T-cell lymphomaSong Hu, Yao Qin, Hong-Mei Yi, et al.
Pediatric Transplantation|January 17, 2022
Safety and long-term outcomes of early liver transplantation for pediatric methylmalonic acidemia patientsNiang-Cheng Lin, Hsin-Lin Tsai, Cheng-Yen Chen, et al.
Signal Transduction and Targeted Therapy|January 19, 2025
Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphomaZhong Zheng, Jian-Biao Wang, Rui Sun, et al.
Pageof 77